» Articles » PMID: 29085786

The 2016 Revision to the World Health Organization Classification of Myelodysplastic Syndromes

Overview
Publisher Sciendo
Specialty General Medicine
Date 2017 Nov 1
PMID 29085786
Citations 31
Authors
Affiliations
Soon will be listed here.
Citing Articles

Redox biomarker levels in patients with myelodysplastic syndrome.

Tsiara E, Makri S, Skaperda Z, Giannakoulas N, Vasilopoulos G, Kouretas D Biomed Rep. 2025; 22(3):45.

PMID: 39882334 PMC: 11775644. DOI: 10.3892/br.2025.1923.


An uncommon triad of myelodysplastic syndrome, Crohn's disease and autoimmune hepatitis: A case report and review of the literature.

Cheffai A, Boufrikha W, Rakez R, Ben Ghechir A, Laatiri M Leuk Res Rep. 2024; 22:100487.

PMID: 39628604 PMC: 11612820. DOI: 10.1016/j.lrr.2024.100487.


Imetelstat for anemia in lower-risk myelodysplastic syndromes: A summary from the Institute for Clinical and Economic Review's California Technology Assessment Forum.

Fahim S, Tice J, Luu L, Carlson J, Richardson M, Herce-Hagiwara B J Manag Care Spec Pharm. 2024; 30(12):1479-1485.

PMID: 39612256 PMC: 11607211. DOI: 10.18553/jmcp.2024.30.12.1479.


Cytogenetic profile and risk of transformation to acute myeloid leukemia (AML) in Indonesian patients with myelodysplastic syndrome (MDS): a pilot study.

Sutandyo N, Kosasih A, Sari R, Setiawan L, Rinaldi I, Maskito V F1000Res. 2024; 13:167.

PMID: 39600341 PMC: 11589415. DOI: 10.12688/f1000research.143170.1.


Peculiar -mer Spectra Are Correlated with 3D Contact Frequencies and Breakpoint Regions in the Human Genome.

Hikmat W, Sievers A, Hausmann M, Hildenbrand G Genes (Basel). 2024; 15(10).

PMID: 39457371 PMC: 11506876. DOI: 10.3390/genes15101247.


References
1.
Bejar R, Stevenson K, Abdel-Wahab O, Galili N, Nilsson B, Garcia-Manero G . Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med. 2011; 364(26):2496-506. PMC: 3159042. DOI: 10.1056/NEJMoa1013343. View

2.
Bejar R, Stevenson K, Caughey B, Lindsley R, Mar B, Stojanov P . Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation. J Clin Oncol. 2014; 32(25):2691-8. PMC: 4207878. DOI: 10.1200/JCO.2013.52.3381. View

3.
Genovese G, Kahler A, Handsaker R, Lindberg J, Rose S, Bakhoum S . Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014; 371(26):2477-87. PMC: 4290021. DOI: 10.1056/NEJMoa1409405. View

4.
Patnaik M, Hanson C, Sulai N, Hodnefield J, Knudson R, Ketterling R . Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts. Blood. 2012; 119(24):5674-7. DOI: 10.1182/blood-2012-03-415356. View

5.
Vardiman J, Thiele J, Arber D, Brunning R, Borowitz M, Porwit A . The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009; 114(5):937-51. DOI: 10.1182/blood-2009-03-209262. View